Business Viyash Scientific ties up with Boehringer Ingelheim to expand companion animal portfolio in India January 23, 2026 gopalkumarthakur@gmail.com India offers tremendous opportunities for innovative medicines which cater to the medical needs of our pets, said Dr. Haribabu Bodepudi, MD & Group CEO of Viyash Scientific Related posts: Dr. Reddy’s introduces Korean firm HK inno.N’s APD drug Tegoprazan in India M&M Q2 net profit rises 16% to ₹3,673 crore, revenue up 22% All-new MINI Convertible launched at ₹58.50 lakh BMW Group India bridges gap with MB, clocks sales of 18,001 units in CY25
